tirzepatide approved for FDA-Approved Tirzepatide: A Game Changer Obesity Treatment FDA approval for Zepbound: FSU

This is the model that we should ideally be following

No Published Human Trials: There are no robust, large-scale human clinical trials showing BPC 157 can safely induce or maintain clinical remission in IBD

Catheter ablation of atrial fibrillation (AF) was economically attractive compared with drug therapy in the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation) trial, investigators have reported in Circulation

Patients losing 24% of body weight at 200 lbs lose approximately 48 lbs

If you're already spending money on prednisone through your insurance, adding compounded tirzepatide at a predictable monthly rate simplifies your medication budget

This article explores the relationship between GLP-1 receptor agonists, gallbladder function, and personalized treatment planning